HomeTocilizumab AazgTocilizumab Aazg + Methotrexate

Does Tocilizumab Aazg Interact with Methotrexate?

Tocilizumab Aazg and Methotrexate have a minor drug interaction according to U.S. FDA drug labeling data. Concomitant administration with tocilizumab had no clinically significant effect on methotrexate exposure. The mechanism involves no effect on tocilizumab clearance. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Tocilizumab Aazg Class
Interleukin-6 Receptor Antagonist
Methotrexate Class
Folate Analog Metabolic Inhibitor
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Tocilizumab Aazg and Methotrexate occurs because no effect on tocilizumab clearance. Clinically, this means concomitant administration with tocilizumab had no clinically significant effect on methotrexate exposure. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Tocilizumab Aazg and your doctor is considering prescribing Methotrexate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tocilizumab Aazg(Tyenne)+💊 Methotrexate(Otrexup)

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Interleukin-6 Receptor Antagonist
Drug B class
Folate Analog Metabolic Inhibitor
Source
NLP:tocilizumab-aazg

What this means in plain English

Concomitant administration with tocilizumab had no clinically significant effect on methotrexate exposure.

About Tocilizumab Aazg and Methotrexate

Tocilizumab Aazg is an Interleukin-6 Receptor Antagonist, while Methotrexate is a Folate Analog Metabolic Inhibitor. You may recognize them by the brand names Tyenne and Otrexup. Tocilizumab Aazg is given by injection under the skin, whereas Methotrexate is given by intramuscular injection. Both Tocilizumab Aazg and Methotrexate carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"No effect on tocilizumab clearance"

📖 Source: NLP:tocilizumab-aazg

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tocilizumab Aazg and Methotrexate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.